medication

Raloxifene

Also known as: Evista

Chemical structure of Raloxifene (PubChem CID 5035)
Structure via PubChem
Half-life
32 h
Typical timing
any
Food rule
either
Default unit
mg

Overview

Raloxifene is a medication classified as a selective estrogen receptor modulator (SERM). It is primarily used to prevent and treat osteoporosis in postmenopausal women. Additionally, it is indicated to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer. It works by mimicking the beneficial effects of estrogen on bone density without affecting the breast or uterine tissues in the same way, thus differing from traditional hormone replacement therapy (FDA label, DrugBank). Raloxifene does not eliminate menopausal symptoms like hot flashes because its estrogenic effects are selective, mainly targeting bone tissue. Its half-life is approximately 32 hours, which contributes to its once-daily dosing regimen. The medication is taken orally and can be consumed with or without food. As a prescription medication, its use must be initiated and monitored by a healthcare professional.

Deep dive

Tap a section to expand.

Known interactions

  • Category rule: supplement × medication
    Note

    Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).

    Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist.

  • Category rule: vitamin × medication
    Note

    Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).

    Specific pairs are checked against a licensed source; confirm with your provider.

Frequently asked

Sources referenced

* Cochrane Library * DrugBank * EMA SmPC (Summary of Product Characteristics) * Examine.com * FDA label (U.S. Food and Drug Administration) * Goodman & Gilman's Pharmacological Basis of Therapeutics * Mayo Clinic * MedlinePlus * National Cancer Institute * NEJM (New England Journal of Medicine) * NICE (National Institute for Health and Care Excellence) * NIH ODS (National Institutes of Health Office of Dietary Supplements) * PubChem * ClinicalTrials.gov

Stackwise compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician.

Related compounds

Others in the medication category or studied for the same goals.

Track Raloxifene in Stackwise

Add it to your stack. We'll schedule doses, check interactions against everything else you take, and remind you at the right time.

Sign up free →